Ketosis clinical trials
The registry lists 218 studies for Ketosis across more than 10 countries. 50 are recruiting or about to start. 89 of them are mainly about Ketosis (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-05. Counting its narrower condition Diabetic Ketoacidosis too: 289 studies, 66 open.
Get an email when these change. Save the Ketosis studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Status
Who runs them
Université de Sherbrooke (18) · University of Aarhus (16) · University of British Columbia (12) · Johns Hopkins University (8) · KU Leuven (7) · Ohio State University (5) · McGill University (5) · University of Pennsylvania (5)
What is being tested here
Drugs under test in Ketosis studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
Drug classes tested here SGLT2 inhibitors 4 open
Coming up
Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.
The 10 nearest, phase 3 first
- Dec 2026Effects of Ketone Supplementation on Acute Alcohol Withdrawal · Phase 3 · University of Pennsylvania
- Nov 2026Variations in Ketone Metabolism · Ohio State University
- Nov 2026Ketones, SGLT2, HFrEF · The University of Texas Health Science Center at San Antonio
- Nov 2026SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research Plan · The University of Texas Health Science Center at San Antonio
- Dec 2026"KETOMED: Ketonemia and Risk of Emergence Delirium in Children Undergoing General Anesthesia - A Multicenter Observational Study" · Hospital Clínico Universitario de Valladolid
- Dec 2026Acetoacetate and Acetate Metabolism in Patients With Chronic Kidney Failure.(RENO-TEP) · Université de Sherbrooke
- Dec 2026Exogenous Ketone Supplementation in ICU Delirium · Vanderbilt University Medical Center
- Dec 2026Nutrition for Asthmatics · Pennington Biomedical Research Center
- Jan 2027Diluted and Undiluted Enteral Nutrition · Medical University of Lublin
- Feb 2027Combining Fasting and Fibre Interventions to Optimise Their Gut Microbiome-mediated Health Benefits · Buchinger Wilhelmi Development & Holding GmbH
Who these studies take
Of the 30 Ketosis studies recruiting now, 6 (20%) set no upper age limit and 22 (73%) stop at 75 or younger. 1 (3%) take children under 18. 3 (10%) are for women only and 2 (7%) for men only; 8 (27%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 23 (77%) | 22 (73%) |
| 30 | 26 (87%) | 26 (87%) |
| 40 | 25 (83%) | 24 (80%) |
| 50 | 18 (60%) | 18 (60%) |
| 65 | 17 (57%) | 16 (53%) |
| 75 | 10 (33%) | 10 (33%) |
| 85 | 6 (20%) | 6 (20%) |
Across all 218 studies, recruiting or not: 57% stop at 75 or younger and 49% at 65; 9% take children; 5% are for women only and 13% for men only; 46% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
How long Ketosis studies take
Of 103 interventional studies with no phase under Ketosis, half reached primary completion within 14 months of starting, counting those still running.
| Start to primary completion | Every sponsor | Industry | Non-industry |
|---|---|---|---|
| Interventional, no phase | 14 mo7–24 · 103 studies | — | 14 mo7–24 · 99 studies |
Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out
What changed recently
From the registry's own updates since Oct 13, 2026.
Started recruiting4
- The ATP Project (Antipsychotic-TEP-Psychosis)Oct 26, 2026NCT06651112
- Health, Imaging, and Cognition Across the Menopausal TransitionOct 26, 2026NCT07021664
- Acute Effects of Ketone Monoester Co-ingestion With Dietary Protein on Whole-body Phenylalanine Oxidation, Phenylalanine Retention, and Myofibrillar Protein Breakdown Following Resistance Exercise in Young Males.Oct 23, 2026NCT07884539
- Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use DisorderOct 21, 2026NCT06807918
Results posted1
Newly registered3
- LIfestyle MEtabotype Study B (LIME-B)Oct 22, 2026NCT07888257
- Acute Effects of Ketone Monoester Co-Ingestion With Dietary Protein on Whole-Body Phenylalanine Oxidation, Phenylalanine Retention, and Myofibrillar Protein Breakdown Following Resistance Exercise in Older MalesOct 20, 2026NCT07884513
- Acute Effects of Ketone Monoester Co-ingestion With Dietary Protein on Whole-body Phenylalanine Oxidation, Phenylalanine Retention, and Myofibrillar Protein Breakdown Following Resistance Exercise in Young Males.Oct 20, 2026NCT07884539
Studies
Recruiting first, then most recently updated. Showing 50 of 218. Browse all 218 → or search them.
- Effects of Ketone Supplementation on Alcohol Withdrawal and Brain Metabolism in Alcohol Use DisorderRecruitingNCT06559995Phase 2/31 country
- Variations in Ketone MetabolismRecruitingNCT05924295Not applicable1 country
- LIfestyle MEtabotype Study B (LIME-B)RecruitingNCT07888257Not applicable1 country
- Health, Imaging, and Cognition Across the Menopausal TransitionRecruitingNCT070216641 country
- The ATP Project (Antipsychotic-TEP-Psychosis)RecruitingNCT066511121 country
- Mitigating DKA in Type 1 Diabetes for Safe Use of SGLT Inhibitors Using Dual Continuous Ketone and Glucose Monitoring.Not yet recruitingNCT07325201Phase 21 country
- Acute Effects of Ketone Monoester Co-ingestion With Dietary Protein on Whole-body Phenylalanine Oxidation, Phenylalanine Retention, and Myofibrillar Protein Breakdown Following Resistance Exercise in Young Males.RecruitingNCT07884539Not applicable1 country
- Effects of Ketones on Brain Energetics and Alcohol Consumption in Alcohol Use DisorderRecruitingNCT06807918Phase 2/31 country
- Acute Effects of Ketone Monoester Co-Ingestion With Dietary Protein on Whole-Body Phenylalanine Oxidation, Phenylalanine Retention, and Myofibrillar Protein Breakdown Following Resistance Exercise in Older MalesNot yet recruitingNCT07884513Not applicable
- Chronic Exogenous Ketosis in HFpEFEnrolling by invitationNCT06937320Phase 21 country
- Combining Fasting and Fibre Interventions to Optimise Their Gut Microbiome-mediated Health BenefitsRecruitingNCT07691736Not applicable1 country
- Ketosis, Immune Function and Metabolic Adaptation in Response to Short-term Fasting in Critical IllnessNot yet recruitingNCT07738536Not applicable1 country
- Endurance Trial: Ketone and Carbohydrate SupplementationRecruitingNCT07792876Not applicable1 country
- Ketones for Opioid CravingRecruitingNCT07128524Phase 21 country
- Exogenous Ketone Supplementation in ICU DeliriumRecruitingNCT07364162Phase 21 country
- Recovery With Exogenous Ketones and AntipsychoticsRecruitingNCT07122531Not applicable1 country
- Specificities of Atypical Non AutoImmune Diabetes (ANAID) in the French West IndiesNot yet recruitingNCT075763741 country
- Prolonged Nasogastric Administration of Ketones in Decompensated Heart FailureRecruitingNCT07527156Phase 41 country
- Effects of Ketone Supplementation on Acute Alcohol WithdrawalEnrolling by invitationNCT06173973Phase 2/31 country
- SGLT2 Inhibitors, Ketones, and Cardiovascular Benefit Research PlanRecruitingNCT05057806Early Phase 11 country
- Effects of Ketone Ester Consumption on Exercise Tolerance and Cardiac FunctionRecruitingNCT06078683Not applicable1 country
- Hemodynamic Effects of Ketone Esters in Patients With Sepsis Induced CardiomyopathyNot yet recruitingNCT06952140Not applicable
- Evaluation of a Novel Insulin Sensitizer in People With Type 1 DiabetesRecruitingNCT07186660Phase 21 country
- Ketones, SGLT2, HFrEFRecruitingNCT06229678Early Phase 11 country
- Undiluted and Diluted NutritionNot yet recruitingNCT07352150Not applicable1 country
- Nutritional Ketosis: a Novel Metabolic Strategy to Treat Lymphedema Patients?RecruitingNCT03991897Not applicable1 country
- Evaluating Safe Ketone Thresholds To Minimise Ketosis in People With Type 1 Diabetes Using DapagliflozinNot yet recruitingNCT07225465Phase 21 country
- The Effects of Ketone Supplements With Carbohydrates on Cycling Performance Above Lactate ThresholdNot yet recruitingNCT07224282Early Phase 11 country
- Investigating the Evolutionary Impact of Metabolic Flexibility on Physical Activity-Dependent BDNF and Cognition: Insights From the Val66Met PolymorphismNot yet recruitingNCT07218497Phase 11 country
- Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled TrialRecruitingNCT06355154Not applicable1 country
- Can the Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Prevent the Increase in Plasma Ketone Concentration?Not yet recruitingNCT06922656Phase 43 countries
- Exogenous KETOne Supplements in Patients Hospitalized for Acute Heart FailureRecruitingNCT06653725Phase 21 country
- Ketogenic Metabolic Therapy in Schizophrenia, Bipolar Disorder, Major Depressive Disorder: Deep Omic ProfilingNot yet recruitingNCT06748950Not applicable1 country
- Validation and Testing of a Novel Continuous Glucose and Continuous Ketone Monitoring Device in Healthy VolunteersRecruitingNCT068779751 country
- The Effect of Acute Exogenous Oral Ketone Supplementation on Immune Cells Function and Immune Cells Histone Β-hydroxybutyrylationRecruitingNCT06590623Not applicable1 country
- Incidence, Characterisation and Outcome-relevance of Perioperative SGLT2 Inhibitor Associated KetoacidosisNot yet recruitingNCT068385071 country
- Type 1 Diabetes Management Using a Very Low Carbohydrate Versus Standard DietRecruitingNCT03710928Not applicable1 country
- Effects of Ketosis on Brain Function in Patients With T1DMRecruitingNCT04219709Not applicable1 country
- Very Low Carbohydrate Diets and Glucagon Response in T1DMRecruitingNCT04200391Not applicable1 country
- Nutrition for AsthmaticsRecruitingNCT06151405Not applicable1 country
- Exogenous Ketones and BehaviorRecruitingNCT06515717Not applicable1 country
- Diluted and Undiluted Enteral NutritionNot yet recruitingNCT06516835Not applicable1 country
- Reduced Carbohydrates + Ketogenic Supplement on Energy MetabolismNot yet recruitingNCT06455982Not applicable1 country
- Acute Effects of Exercise Combined With Ketone Ester SupplementNot yet recruitingNCT06365957Not applicable
- The Effect of Ketone Ester Supplementation and Ketogenic Diet on Brain Plasticity in Overweight/Obese AdultsNot yet recruitingNCT06368297Not applicable
- The Impact of Different Carbohydrate Restriction After a Gastric Bypass on the Ketosis and KetoacidosisRecruitingNCT06338969Not applicable1 country
- Ketogenic Diet for Psychotic DisordersRecruitingNCT03873922Not applicable1 country
- Acceptability/Tolerance of Protein Substitutes in Tablet Form for the Dietary Management of Rare AminoacidopathiesNot yet recruitingNCT06298292
- Brain Substrate Switch to Ketones and LactateNot yet recruitingNCT06000605Not applicable1 country
- Ketonemia Through Menstrual CycleRecruitingNCT052344111 country